Beacon has launched new anti-cancer drugs in injection form under the brand name Nivomab.The medicine under the generic of Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC).
It is suggested for slow injection into vein of the patients suffering from such type of cancer only for export purpose.
Product Name | Nivomab |
Generic Name | Nivolumab |
Therapeutic Class | Immunotherapy (PD-1 Inhibitor) |
Formulation | Injection |
Available Pack Size | 1x1’s |
Available Strength | 100 mg, 40 mg |